Global Montelukast Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Montelukast Industry Forecast” looks at past sales and reviews total world Montelukast sales in 2022, providing a comprehensive analysis by region and market sector of projected Montelukast sales for 2023 through 2029. With Montelukast sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast industry.
This Insight Report provides a comprehensive analysis of the global Montelukast landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Montelukast market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast.
The global Montelukast market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Montelukast is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Montelukast is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Montelukast is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Montelukast players cover Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies and Jubilant Cadista, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Montelukast market?
What factors are driving Montelukast market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast market opportunities vary by end market size?
How does Montelukast break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Montelukast Industry Forecast” looks at past sales and reviews total world Montelukast sales in 2022, providing a comprehensive analysis by region and market sector of projected Montelukast sales for 2023 through 2029. With Montelukast sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast industry.
This Insight Report provides a comprehensive analysis of the global Montelukast landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Montelukast market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast.
The global Montelukast market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Montelukast is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Montelukast is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Montelukast is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Montelukast players cover Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies and Jubilant Cadista, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Montelukast Amorphous
- Montelukast Crystalline
- Tablets
- Chewable Tablet
- Oral Solution
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Morepen Laboratories
- Mylan
- TAPI
- MSN Laboratories
- Ultratech India
- Aurobindo Pharma
- Hetero Labs
- Unimark Remedies
- Jubilant Cadista
- Aamorb Pharmaceuticals
- Sudarshan Groups
- Ortin Laboratories
- Vamsi Labs
- Adley Group
- Medopharm
- Hengyuan Pharmaceutical
- Arromax Pharmaceutical Technology
- Lihe Wuhan New Chemical Materials
- Shanghai Huachu Chemical
What is the 10-year outlook for the global Montelukast market?
What factors are driving Montelukast market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast market opportunities vary by end market size?
How does Montelukast break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Montelukast Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Montelukast by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Montelukast by Country/Region, 2018, 2022 & 2029
2.2 Montelukast Segment by Type
2.2.1 Montelukast Amorphous
2.2.2 Montelukast Crystalline
2.3 Montelukast Sales by Type
2.3.1 Global Montelukast Sales Market Share by Type (2018-2023)
2.3.2 Global Montelukast Revenue and Market Share by Type (2018-2023)
2.3.3 Global Montelukast Sale Price by Type (2018-2023)
2.4 Montelukast Segment by Application
2.4.1 Tablets
2.4.2 Chewable Tablet
2.4.3 Oral Solution
2.5 Montelukast Sales by Application
2.5.1 Global Montelukast Sale Market Share by Application (2018-2023)
2.5.2 Global Montelukast Revenue and Market Share by Application (2018-2023)
2.5.3 Global Montelukast Sale Price by Application (2018-2023)
3 GLOBAL MONTELUKAST BY COMPANY
3.1 Global Montelukast Breakdown Data by Company
3.1.1 Global Montelukast Annual Sales by Company (2018-2023)
3.1.2 Global Montelukast Sales Market Share by Company (2018-2023)
3.2 Global Montelukast Annual Revenue by Company (2018-2023)
3.2.1 Global Montelukast Revenue by Company (2018-2023)
3.2.2 Global Montelukast Revenue Market Share by Company (2018-2023)
3.3 Global Montelukast Sale Price by Company
3.4 Key Manufacturers Montelukast Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Product Location Distribution
3.4.2 Players Montelukast Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MONTELUKAST BY GEOGRAPHIC REGION
4.1 World Historic Montelukast Market Size by Geographic Region (2018-2023)
4.1.1 Global Montelukast Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Montelukast Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Montelukast Market Size by Country/Region (2018-2023)
4.2.1 Global Montelukast Annual Sales by Country/Region (2018-2023)
4.2.2 Global Montelukast Annual Revenue by Country/Region (2018-2023)
4.3 Americas Montelukast Sales Growth
4.4 APAC Montelukast Sales Growth
4.5 Europe Montelukast Sales Growth
4.6 Middle East & Africa Montelukast Sales Growth
5 AMERICAS
5.1 Americas Montelukast Sales by Country
5.1.1 Americas Montelukast Sales by Country (2018-2023)
5.1.2 Americas Montelukast Revenue by Country (2018-2023)
5.2 Americas Montelukast Sales by Type
5.3 Americas Montelukast Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Sales by Region
6.1.1 APAC Montelukast Sales by Region (2018-2023)
6.1.2 APAC Montelukast Revenue by Region (2018-2023)
6.2 APAC Montelukast Sales by Type
6.3 APAC Montelukast Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Montelukast by Country
7.1.1 Europe Montelukast Sales by Country (2018-2023)
7.1.2 Europe Montelukast Revenue by Country (2018-2023)
7.2 Europe Montelukast Sales by Type
7.3 Europe Montelukast Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Montelukast by Country
8.1.1 Middle East & Africa Montelukast Sales by Country (2018-2023)
8.1.2 Middle East & Africa Montelukast Revenue by Country (2018-2023)
8.2 Middle East & Africa Montelukast Sales by Type
8.3 Middle East & Africa Montelukast Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast
10.3 Manufacturing Process Analysis of Montelukast
10.4 Industry Chain Structure of Montelukast
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Distributors
11.3 Montelukast Customer
12 WORLD FORECAST REVIEW FOR MONTELUKAST BY GEOGRAPHIC REGION
12.1 Global Montelukast Market Size Forecast by Region
12.1.1 Global Montelukast Forecast by Region (2024-2029)
12.1.2 Global Montelukast Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Forecast by Type
12.7 Global Montelukast Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Morepen Laboratories
13.1.1 Morepen Laboratories Company Information
13.1.2 Morepen Laboratories Montelukast Product Portfolios and Specifications
13.1.3 Morepen Laboratories Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Morepen Laboratories Main Business Overview
13.1.5 Morepen Laboratories Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Montelukast Product Portfolios and Specifications
13.2.3 Mylan Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 TAPI
13.3.1 TAPI Company Information
13.3.2 TAPI Montelukast Product Portfolios and Specifications
13.3.3 TAPI Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 TAPI Main Business Overview
13.3.5 TAPI Latest Developments
13.4 MSN Laboratories
13.4.1 MSN Laboratories Company Information
13.4.2 MSN Laboratories Montelukast Product Portfolios and Specifications
13.4.3 MSN Laboratories Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MSN Laboratories Main Business Overview
13.4.5 MSN Laboratories Latest Developments
13.5 Ultratech India
13.5.1 Ultratech India Company Information
13.5.2 Ultratech India Montelukast Product Portfolios and Specifications
13.5.3 Ultratech India Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ultratech India Main Business Overview
13.5.5 Ultratech India Latest Developments
13.6 Aurobindo Pharma
13.6.1 Aurobindo Pharma Company Information
13.6.2 Aurobindo Pharma Montelukast Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurobindo Pharma Main Business Overview
13.6.5 Aurobindo Pharma Latest Developments
13.7 Hetero Labs
13.7.1 Hetero Labs Company Information
13.7.2 Hetero Labs Montelukast Product Portfolios and Specifications
13.7.3 Hetero Labs Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hetero Labs Main Business Overview
13.7.5 Hetero Labs Latest Developments
13.8 Unimark Remedies
13.8.1 Unimark Remedies Company Information
13.8.2 Unimark Remedies Montelukast Product Portfolios and Specifications
13.8.3 Unimark Remedies Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Unimark Remedies Main Business Overview
13.8.5 Unimark Remedies Latest Developments
13.9 Jubilant Cadista
13.9.1 Jubilant Cadista Company Information
13.9.2 Jubilant Cadista Montelukast Product Portfolios and Specifications
13.9.3 Jubilant Cadista Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Jubilant Cadista Main Business Overview
13.9.5 Jubilant Cadista Latest Developments
13.10 Aamorb Pharmaceuticals
13.10.1 Aamorb Pharmaceuticals Company Information
13.10.2 Aamorb Pharmaceuticals Montelukast Product Portfolios and Specifications
13.10.3 Aamorb Pharmaceuticals Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Aamorb Pharmaceuticals Main Business Overview
13.10.5 Aamorb Pharmaceuticals Latest Developments
13.11 Sudarshan Groups
13.11.1 Sudarshan Groups Company Information
13.11.2 Sudarshan Groups Montelukast Product Portfolios and Specifications
13.11.3 Sudarshan Groups Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sudarshan Groups Main Business Overview
13.11.5 Sudarshan Groups Latest Developments
13.12 Ortin Laboratories
13.12.1 Ortin Laboratories Company Information
13.12.2 Ortin Laboratories Montelukast Product Portfolios and Specifications
13.12.3 Ortin Laboratories Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ortin Laboratories Main Business Overview
13.12.5 Ortin Laboratories Latest Developments
13.13 Vamsi Labs
13.13.1 Vamsi Labs Company Information
13.13.2 Vamsi Labs Montelukast Product Portfolios and Specifications
13.13.3 Vamsi Labs Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Vamsi Labs Main Business Overview
13.13.5 Vamsi Labs Latest Developments
13.14 Adley Group
13.14.1 Adley Group Company Information
13.14.2 Adley Group Montelukast Product Portfolios and Specifications
13.14.3 Adley Group Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Adley Group Main Business Overview
13.14.5 Adley Group Latest Developments
13.15 Medopharm
13.15.1 Medopharm Company Information
13.15.2 Medopharm Montelukast Product Portfolios and Specifications
13.15.3 Medopharm Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Medopharm Main Business Overview
13.15.5 Medopharm Latest Developments
13.16 Hengyuan Pharmaceutical
13.16.1 Hengyuan Pharmaceutical Company Information
13.16.2 Hengyuan Pharmaceutical Montelukast Product Portfolios and Specifications
13.16.3 Hengyuan Pharmaceutical Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Hengyuan Pharmaceutical Main Business Overview
13.16.5 Hengyuan Pharmaceutical Latest Developments
13.17 Arromax Pharmaceutical Technology
13.17.1 Arromax Pharmaceutical Technology Company Information
13.17.2 Arromax Pharmaceutical Technology Montelukast Product Portfolios and Specifications
13.17.3 Arromax Pharmaceutical Technology Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Arromax Pharmaceutical Technology Main Business Overview
13.17.5 Arromax Pharmaceutical Technology Latest Developments
13.18 Lihe Wuhan New Chemical Materials
13.18.1 Lihe Wuhan New Chemical Materials Company Information
13.18.2 Lihe Wuhan New Chemical Materials Montelukast Product Portfolios and Specifications
13.18.3 Lihe Wuhan New Chemical Materials Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Lihe Wuhan New Chemical Materials Main Business Overview
13.18.5 Lihe Wuhan New Chemical Materials Latest Developments
13.19 Shanghai Huachu Chemical
13.19.1 Shanghai Huachu Chemical Company Information
13.19.2 Shanghai Huachu Chemical Montelukast Product Portfolios and Specifications
13.19.3 Shanghai Huachu Chemical Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shanghai Huachu Chemical Main Business Overview
13.19.5 Shanghai Huachu Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Montelukast Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Montelukast by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Montelukast by Country/Region, 2018, 2022 & 2029
2.2 Montelukast Segment by Type
2.2.1 Montelukast Amorphous
2.2.2 Montelukast Crystalline
2.3 Montelukast Sales by Type
2.3.1 Global Montelukast Sales Market Share by Type (2018-2023)
2.3.2 Global Montelukast Revenue and Market Share by Type (2018-2023)
2.3.3 Global Montelukast Sale Price by Type (2018-2023)
2.4 Montelukast Segment by Application
2.4.1 Tablets
2.4.2 Chewable Tablet
2.4.3 Oral Solution
2.5 Montelukast Sales by Application
2.5.1 Global Montelukast Sale Market Share by Application (2018-2023)
2.5.2 Global Montelukast Revenue and Market Share by Application (2018-2023)
2.5.3 Global Montelukast Sale Price by Application (2018-2023)
3 GLOBAL MONTELUKAST BY COMPANY
3.1 Global Montelukast Breakdown Data by Company
3.1.1 Global Montelukast Annual Sales by Company (2018-2023)
3.1.2 Global Montelukast Sales Market Share by Company (2018-2023)
3.2 Global Montelukast Annual Revenue by Company (2018-2023)
3.2.1 Global Montelukast Revenue by Company (2018-2023)
3.2.2 Global Montelukast Revenue Market Share by Company (2018-2023)
3.3 Global Montelukast Sale Price by Company
3.4 Key Manufacturers Montelukast Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Product Location Distribution
3.4.2 Players Montelukast Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MONTELUKAST BY GEOGRAPHIC REGION
4.1 World Historic Montelukast Market Size by Geographic Region (2018-2023)
4.1.1 Global Montelukast Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Montelukast Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Montelukast Market Size by Country/Region (2018-2023)
4.2.1 Global Montelukast Annual Sales by Country/Region (2018-2023)
4.2.2 Global Montelukast Annual Revenue by Country/Region (2018-2023)
4.3 Americas Montelukast Sales Growth
4.4 APAC Montelukast Sales Growth
4.5 Europe Montelukast Sales Growth
4.6 Middle East & Africa Montelukast Sales Growth
5 AMERICAS
5.1 Americas Montelukast Sales by Country
5.1.1 Americas Montelukast Sales by Country (2018-2023)
5.1.2 Americas Montelukast Revenue by Country (2018-2023)
5.2 Americas Montelukast Sales by Type
5.3 Americas Montelukast Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Sales by Region
6.1.1 APAC Montelukast Sales by Region (2018-2023)
6.1.2 APAC Montelukast Revenue by Region (2018-2023)
6.2 APAC Montelukast Sales by Type
6.3 APAC Montelukast Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Montelukast by Country
7.1.1 Europe Montelukast Sales by Country (2018-2023)
7.1.2 Europe Montelukast Revenue by Country (2018-2023)
7.2 Europe Montelukast Sales by Type
7.3 Europe Montelukast Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Montelukast by Country
8.1.1 Middle East & Africa Montelukast Sales by Country (2018-2023)
8.1.2 Middle East & Africa Montelukast Revenue by Country (2018-2023)
8.2 Middle East & Africa Montelukast Sales by Type
8.3 Middle East & Africa Montelukast Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast
10.3 Manufacturing Process Analysis of Montelukast
10.4 Industry Chain Structure of Montelukast
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Distributors
11.3 Montelukast Customer
12 WORLD FORECAST REVIEW FOR MONTELUKAST BY GEOGRAPHIC REGION
12.1 Global Montelukast Market Size Forecast by Region
12.1.1 Global Montelukast Forecast by Region (2024-2029)
12.1.2 Global Montelukast Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Forecast by Type
12.7 Global Montelukast Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Morepen Laboratories
13.1.1 Morepen Laboratories Company Information
13.1.2 Morepen Laboratories Montelukast Product Portfolios and Specifications
13.1.3 Morepen Laboratories Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Morepen Laboratories Main Business Overview
13.1.5 Morepen Laboratories Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Montelukast Product Portfolios and Specifications
13.2.3 Mylan Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 TAPI
13.3.1 TAPI Company Information
13.3.2 TAPI Montelukast Product Portfolios and Specifications
13.3.3 TAPI Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 TAPI Main Business Overview
13.3.5 TAPI Latest Developments
13.4 MSN Laboratories
13.4.1 MSN Laboratories Company Information
13.4.2 MSN Laboratories Montelukast Product Portfolios and Specifications
13.4.3 MSN Laboratories Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MSN Laboratories Main Business Overview
13.4.5 MSN Laboratories Latest Developments
13.5 Ultratech India
13.5.1 Ultratech India Company Information
13.5.2 Ultratech India Montelukast Product Portfolios and Specifications
13.5.3 Ultratech India Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ultratech India Main Business Overview
13.5.5 Ultratech India Latest Developments
13.6 Aurobindo Pharma
13.6.1 Aurobindo Pharma Company Information
13.6.2 Aurobindo Pharma Montelukast Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurobindo Pharma Main Business Overview
13.6.5 Aurobindo Pharma Latest Developments
13.7 Hetero Labs
13.7.1 Hetero Labs Company Information
13.7.2 Hetero Labs Montelukast Product Portfolios and Specifications
13.7.3 Hetero Labs Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hetero Labs Main Business Overview
13.7.5 Hetero Labs Latest Developments
13.8 Unimark Remedies
13.8.1 Unimark Remedies Company Information
13.8.2 Unimark Remedies Montelukast Product Portfolios and Specifications
13.8.3 Unimark Remedies Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Unimark Remedies Main Business Overview
13.8.5 Unimark Remedies Latest Developments
13.9 Jubilant Cadista
13.9.1 Jubilant Cadista Company Information
13.9.2 Jubilant Cadista Montelukast Product Portfolios and Specifications
13.9.3 Jubilant Cadista Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Jubilant Cadista Main Business Overview
13.9.5 Jubilant Cadista Latest Developments
13.10 Aamorb Pharmaceuticals
13.10.1 Aamorb Pharmaceuticals Company Information
13.10.2 Aamorb Pharmaceuticals Montelukast Product Portfolios and Specifications
13.10.3 Aamorb Pharmaceuticals Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Aamorb Pharmaceuticals Main Business Overview
13.10.5 Aamorb Pharmaceuticals Latest Developments
13.11 Sudarshan Groups
13.11.1 Sudarshan Groups Company Information
13.11.2 Sudarshan Groups Montelukast Product Portfolios and Specifications
13.11.3 Sudarshan Groups Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sudarshan Groups Main Business Overview
13.11.5 Sudarshan Groups Latest Developments
13.12 Ortin Laboratories
13.12.1 Ortin Laboratories Company Information
13.12.2 Ortin Laboratories Montelukast Product Portfolios and Specifications
13.12.3 Ortin Laboratories Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ortin Laboratories Main Business Overview
13.12.5 Ortin Laboratories Latest Developments
13.13 Vamsi Labs
13.13.1 Vamsi Labs Company Information
13.13.2 Vamsi Labs Montelukast Product Portfolios and Specifications
13.13.3 Vamsi Labs Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Vamsi Labs Main Business Overview
13.13.5 Vamsi Labs Latest Developments
13.14 Adley Group
13.14.1 Adley Group Company Information
13.14.2 Adley Group Montelukast Product Portfolios and Specifications
13.14.3 Adley Group Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Adley Group Main Business Overview
13.14.5 Adley Group Latest Developments
13.15 Medopharm
13.15.1 Medopharm Company Information
13.15.2 Medopharm Montelukast Product Portfolios and Specifications
13.15.3 Medopharm Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Medopharm Main Business Overview
13.15.5 Medopharm Latest Developments
13.16 Hengyuan Pharmaceutical
13.16.1 Hengyuan Pharmaceutical Company Information
13.16.2 Hengyuan Pharmaceutical Montelukast Product Portfolios and Specifications
13.16.3 Hengyuan Pharmaceutical Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Hengyuan Pharmaceutical Main Business Overview
13.16.5 Hengyuan Pharmaceutical Latest Developments
13.17 Arromax Pharmaceutical Technology
13.17.1 Arromax Pharmaceutical Technology Company Information
13.17.2 Arromax Pharmaceutical Technology Montelukast Product Portfolios and Specifications
13.17.3 Arromax Pharmaceutical Technology Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Arromax Pharmaceutical Technology Main Business Overview
13.17.5 Arromax Pharmaceutical Technology Latest Developments
13.18 Lihe Wuhan New Chemical Materials
13.18.1 Lihe Wuhan New Chemical Materials Company Information
13.18.2 Lihe Wuhan New Chemical Materials Montelukast Product Portfolios and Specifications
13.18.3 Lihe Wuhan New Chemical Materials Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Lihe Wuhan New Chemical Materials Main Business Overview
13.18.5 Lihe Wuhan New Chemical Materials Latest Developments
13.19 Shanghai Huachu Chemical
13.19.1 Shanghai Huachu Chemical Company Information
13.19.2 Shanghai Huachu Chemical Montelukast Product Portfolios and Specifications
13.19.3 Shanghai Huachu Chemical Montelukast Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shanghai Huachu Chemical Main Business Overview
13.19.5 Shanghai Huachu Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Montelukast Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Montelukast Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Montelukast Amorphous
Table 4. Major Players of Montelukast Crystalline
Table 5. Global Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 6. Global Montelukast Sales Market Share by Type (2018-2023)
Table 7. Global Montelukast Revenue by Type (2018-2023) & ($ million)
Table 8. Global Montelukast Revenue Market Share by Type (2018-2023)
Table 9. Global Montelukast Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 11. Global Montelukast Sales Market Share by Application (2018-2023)
Table 12. Global Montelukast Revenue by Application (2018-2023)
Table 13. Global Montelukast Revenue Market Share by Application (2018-2023)
Table 14. Global Montelukast Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Montelukast Sales by Company (2018-2023) & (Kiloton)
Table 16. Global Montelukast Sales Market Share by Company (2018-2023)
Table 17. Global Montelukast Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Montelukast Revenue Market Share by Company (2018-2023)
Table 19. Global Montelukast Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Montelukast Producing Area Distribution and Sales Area
Table 21. Players Montelukast Products Offered
Table 22. Montelukast Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Montelukast Sales by Geographic Region (2018-2023) & (Kiloton)
Table 26. Global Montelukast Sales Market Share Geographic Region (2018-2023)
Table 27. Global Montelukast Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Montelukast Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Montelukast Sales by Country/Region (2018-2023) & (Kiloton)
Table 30. Global Montelukast Sales Market Share by Country/Region (2018-2023)
Table 31. Global Montelukast Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Montelukast Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Montelukast Sales by Country (2018-2023) & (Kiloton)
Table 34. Americas Montelukast Sales Market Share by Country (2018-2023)
Table 35. Americas Montelukast Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Montelukast Revenue Market Share by Country (2018-2023)
Table 37. Americas Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 38. Americas Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 39. APAC Montelukast Sales by Region (2018-2023) & (Kiloton)
Table 40. APAC Montelukast Sales Market Share by Region (2018-2023)
Table 41. APAC Montelukast Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Montelukast Revenue Market Share by Region (2018-2023)
Table 43. APAC Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 44. APAC Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 45. Europe Montelukast Sales by Country (2018-2023) & (Kiloton)
Table 46. Europe Montelukast Sales Market Share by Country (2018-2023)
Table 47. Europe Montelukast Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Montelukast Revenue Market Share by Country (2018-2023)
Table 49. Europe Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 50. Europe Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 51. Middle East & Africa Montelukast Sales by Country (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Montelukast Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Montelukast Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Montelukast Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 57. Key Market Drivers & Growth Opportunities of Montelukast
Table 58. Key Market Challenges & Risks of Montelukast
Table 59. Key Industry Trends of Montelukast
Table 60. Montelukast Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Montelukast Distributors List
Table 63. Montelukast Customer List
Table 64. Global Montelukast Sales Forecast by Region (2024-2029) & (Kiloton)
Table 65. Global Montelukast Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Montelukast Sales Forecast by Country (2024-2029) & (Kiloton)
Table 67. Americas Montelukast Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Montelukast Sales Forecast by Region (2024-2029) & (Kiloton)
Table 69. APAC Montelukast Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Montelukast Sales Forecast by Country (2024-2029) & (Kiloton)
Table 71. Europe Montelukast Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Montelukast Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Middle East & Africa Montelukast Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Montelukast Sales Forecast by Type (2024-2029) & (Kiloton)
Table 75. Global Montelukast Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Montelukast Sales Forecast by Application (2024-2029) & (Kiloton)
Table 77. Global Montelukast Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Morepen Laboratories Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 79. Morepen Laboratories Montelukast Product Portfolios and Specifications
Table 80. Morepen Laboratories Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Morepen Laboratories Main Business
Table 82. Morepen Laboratories Latest Developments
Table 83. Mylan Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 84. Mylan Montelukast Product Portfolios and Specifications
Table 85. Mylan Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Mylan Main Business
Table 87. Mylan Latest Developments
Table 88. TAPI Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 89. TAPI Montelukast Product Portfolios and Specifications
Table 90. TAPI Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. TAPI Main Business
Table 92. TAPI Latest Developments
Table 93. MSN Laboratories Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 94. MSN Laboratories Montelukast Product Portfolios and Specifications
Table 95. MSN Laboratories Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. MSN Laboratories Main Business
Table 97. MSN Laboratories Latest Developments
Table 98. Ultratech India Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 99. Ultratech India Montelukast Product Portfolios and Specifications
Table 100. Ultratech India Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Ultratech India Main Business
Table 102. Ultratech India Latest Developments
Table 103. Aurobindo Pharma Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Pharma Montelukast Product Portfolios and Specifications
Table 105. Aurobindo Pharma Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Aurobindo Pharma Main Business
Table 107. Aurobindo Pharma Latest Developments
Table 108. Hetero Labs Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 109. Hetero Labs Montelukast Product Portfolios and Specifications
Table 110. Hetero Labs Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Hetero Labs Main Business
Table 112. Hetero Labs Latest Developments
Table 113. Unimark Remedies Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 114. Unimark Remedies Montelukast Product Portfolios and Specifications
Table 115. Unimark Remedies Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Unimark Remedies Main Business
Table 117. Unimark Remedies Latest Developments
Table 118. Jubilant Cadista Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 119. Jubilant Cadista Montelukast Product Portfolios and Specifications
Table 120. Jubilant Cadista Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Jubilant Cadista Main Business
Table 122. Jubilant Cadista Latest Developments
Table 123. Aamorb Pharmaceuticals Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 124. Aamorb Pharmaceuticals Montelukast Product Portfolios and Specifications
Table 125. Aamorb Pharmaceuticals Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Aamorb Pharmaceuticals Main Business
Table 127. Aamorb Pharmaceuticals Latest Developments
Table 128. Sudarshan Groups Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 129. Sudarshan Groups Montelukast Product Portfolios and Specifications
Table 130. Sudarshan Groups Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Sudarshan Groups Main Business
Table 132. Sudarshan Groups Latest Developments
Table 133. Ortin Laboratories Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 134. Ortin Laboratories Montelukast Product Portfolios and Specifications
Table 135. Ortin Laboratories Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Ortin Laboratories Main Business
Table 137. Ortin Laboratories Latest Developments
Table 138. Vamsi Labs Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 139. Vamsi Labs Montelukast Product Portfolios and Specifications
Table 140. Vamsi Labs Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Vamsi Labs Main Business
Table 142. Vamsi Labs Latest Developments
Table 143. Adley Group Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 144. Adley Group Montelukast Product Portfolios and Specifications
Table 145. Adley Group Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Adley Group Main Business
Table 147. Adley Group Latest Developments
Table 148. Medopharm Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 149. Medopharm Montelukast Product Portfolios and Specifications
Table 150. Medopharm Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. Medopharm Main Business
Table 152. Medopharm Latest Developments
Table 153. Hengyuan Pharmaceutical Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 154. Hengyuan Pharmaceutical Montelukast Product Portfolios and Specifications
Table 155. Hengyuan Pharmaceutical Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Hengyuan Pharmaceutical Main Business
Table 157. Hengyuan Pharmaceutical Latest Developments
Table 158. Arromax Pharmaceutical Technology Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 159. Arromax Pharmaceutical Technology Montelukast Product Portfolios and Specifications
Table 160. Arromax Pharmaceutical Technology Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 161. Arromax Pharmaceutical Technology Main Business
Table 162. Arromax Pharmaceutical Technology Latest Developments
Table 163. Lihe Wuhan New Chemical Materials Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 164. Lihe Wuhan New Chemical Materials Montelukast Product Portfolios and Specifications
Table 165. Lihe Wuhan New Chemical Materials Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 166. Lihe Wuhan New Chemical Materials Main Business
Table 167. Lihe Wuhan New Chemical Materials Latest Developments
Table 168. Shanghai Huachu Chemical Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 169. Shanghai Huachu Chemical Montelukast Product Portfolios and Specifications
Table 170. Shanghai Huachu Chemical Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 171. Shanghai Huachu Chemical Main Business
Table 172. Shanghai Huachu Chemical Latest Developments
Table 1. Montelukast Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Montelukast Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Montelukast Amorphous
Table 4. Major Players of Montelukast Crystalline
Table 5. Global Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 6. Global Montelukast Sales Market Share by Type (2018-2023)
Table 7. Global Montelukast Revenue by Type (2018-2023) & ($ million)
Table 8. Global Montelukast Revenue Market Share by Type (2018-2023)
Table 9. Global Montelukast Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 11. Global Montelukast Sales Market Share by Application (2018-2023)
Table 12. Global Montelukast Revenue by Application (2018-2023)
Table 13. Global Montelukast Revenue Market Share by Application (2018-2023)
Table 14. Global Montelukast Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Montelukast Sales by Company (2018-2023) & (Kiloton)
Table 16. Global Montelukast Sales Market Share by Company (2018-2023)
Table 17. Global Montelukast Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Montelukast Revenue Market Share by Company (2018-2023)
Table 19. Global Montelukast Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Montelukast Producing Area Distribution and Sales Area
Table 21. Players Montelukast Products Offered
Table 22. Montelukast Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Montelukast Sales by Geographic Region (2018-2023) & (Kiloton)
Table 26. Global Montelukast Sales Market Share Geographic Region (2018-2023)
Table 27. Global Montelukast Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Montelukast Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Montelukast Sales by Country/Region (2018-2023) & (Kiloton)
Table 30. Global Montelukast Sales Market Share by Country/Region (2018-2023)
Table 31. Global Montelukast Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Montelukast Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Montelukast Sales by Country (2018-2023) & (Kiloton)
Table 34. Americas Montelukast Sales Market Share by Country (2018-2023)
Table 35. Americas Montelukast Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Montelukast Revenue Market Share by Country (2018-2023)
Table 37. Americas Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 38. Americas Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 39. APAC Montelukast Sales by Region (2018-2023) & (Kiloton)
Table 40. APAC Montelukast Sales Market Share by Region (2018-2023)
Table 41. APAC Montelukast Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Montelukast Revenue Market Share by Region (2018-2023)
Table 43. APAC Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 44. APAC Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 45. Europe Montelukast Sales by Country (2018-2023) & (Kiloton)
Table 46. Europe Montelukast Sales Market Share by Country (2018-2023)
Table 47. Europe Montelukast Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Montelukast Revenue Market Share by Country (2018-2023)
Table 49. Europe Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 50. Europe Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 51. Middle East & Africa Montelukast Sales by Country (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Montelukast Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Montelukast Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Montelukast Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Montelukast Sales by Type (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Montelukast Sales by Application (2018-2023) & (Kiloton)
Table 57. Key Market Drivers & Growth Opportunities of Montelukast
Table 58. Key Market Challenges & Risks of Montelukast
Table 59. Key Industry Trends of Montelukast
Table 60. Montelukast Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Montelukast Distributors List
Table 63. Montelukast Customer List
Table 64. Global Montelukast Sales Forecast by Region (2024-2029) & (Kiloton)
Table 65. Global Montelukast Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Montelukast Sales Forecast by Country (2024-2029) & (Kiloton)
Table 67. Americas Montelukast Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Montelukast Sales Forecast by Region (2024-2029) & (Kiloton)
Table 69. APAC Montelukast Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Montelukast Sales Forecast by Country (2024-2029) & (Kiloton)
Table 71. Europe Montelukast Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Montelukast Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Middle East & Africa Montelukast Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Montelukast Sales Forecast by Type (2024-2029) & (Kiloton)
Table 75. Global Montelukast Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Montelukast Sales Forecast by Application (2024-2029) & (Kiloton)
Table 77. Global Montelukast Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Morepen Laboratories Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 79. Morepen Laboratories Montelukast Product Portfolios and Specifications
Table 80. Morepen Laboratories Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Morepen Laboratories Main Business
Table 82. Morepen Laboratories Latest Developments
Table 83. Mylan Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 84. Mylan Montelukast Product Portfolios and Specifications
Table 85. Mylan Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Mylan Main Business
Table 87. Mylan Latest Developments
Table 88. TAPI Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 89. TAPI Montelukast Product Portfolios and Specifications
Table 90. TAPI Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. TAPI Main Business
Table 92. TAPI Latest Developments
Table 93. MSN Laboratories Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 94. MSN Laboratories Montelukast Product Portfolios and Specifications
Table 95. MSN Laboratories Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. MSN Laboratories Main Business
Table 97. MSN Laboratories Latest Developments
Table 98. Ultratech India Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 99. Ultratech India Montelukast Product Portfolios and Specifications
Table 100. Ultratech India Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Ultratech India Main Business
Table 102. Ultratech India Latest Developments
Table 103. Aurobindo Pharma Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Pharma Montelukast Product Portfolios and Specifications
Table 105. Aurobindo Pharma Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Aurobindo Pharma Main Business
Table 107. Aurobindo Pharma Latest Developments
Table 108. Hetero Labs Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 109. Hetero Labs Montelukast Product Portfolios and Specifications
Table 110. Hetero Labs Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Hetero Labs Main Business
Table 112. Hetero Labs Latest Developments
Table 113. Unimark Remedies Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 114. Unimark Remedies Montelukast Product Portfolios and Specifications
Table 115. Unimark Remedies Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Unimark Remedies Main Business
Table 117. Unimark Remedies Latest Developments
Table 118. Jubilant Cadista Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 119. Jubilant Cadista Montelukast Product Portfolios and Specifications
Table 120. Jubilant Cadista Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Jubilant Cadista Main Business
Table 122. Jubilant Cadista Latest Developments
Table 123. Aamorb Pharmaceuticals Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 124. Aamorb Pharmaceuticals Montelukast Product Portfolios and Specifications
Table 125. Aamorb Pharmaceuticals Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Aamorb Pharmaceuticals Main Business
Table 127. Aamorb Pharmaceuticals Latest Developments
Table 128. Sudarshan Groups Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 129. Sudarshan Groups Montelukast Product Portfolios and Specifications
Table 130. Sudarshan Groups Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Sudarshan Groups Main Business
Table 132. Sudarshan Groups Latest Developments
Table 133. Ortin Laboratories Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 134. Ortin Laboratories Montelukast Product Portfolios and Specifications
Table 135. Ortin Laboratories Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Ortin Laboratories Main Business
Table 137. Ortin Laboratories Latest Developments
Table 138. Vamsi Labs Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 139. Vamsi Labs Montelukast Product Portfolios and Specifications
Table 140. Vamsi Labs Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Vamsi Labs Main Business
Table 142. Vamsi Labs Latest Developments
Table 143. Adley Group Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 144. Adley Group Montelukast Product Portfolios and Specifications
Table 145. Adley Group Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Adley Group Main Business
Table 147. Adley Group Latest Developments
Table 148. Medopharm Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 149. Medopharm Montelukast Product Portfolios and Specifications
Table 150. Medopharm Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. Medopharm Main Business
Table 152. Medopharm Latest Developments
Table 153. Hengyuan Pharmaceutical Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 154. Hengyuan Pharmaceutical Montelukast Product Portfolios and Specifications
Table 155. Hengyuan Pharmaceutical Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Hengyuan Pharmaceutical Main Business
Table 157. Hengyuan Pharmaceutical Latest Developments
Table 158. Arromax Pharmaceutical Technology Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 159. Arromax Pharmaceutical Technology Montelukast Product Portfolios and Specifications
Table 160. Arromax Pharmaceutical Technology Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 161. Arromax Pharmaceutical Technology Main Business
Table 162. Arromax Pharmaceutical Technology Latest Developments
Table 163. Lihe Wuhan New Chemical Materials Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 164. Lihe Wuhan New Chemical Materials Montelukast Product Portfolios and Specifications
Table 165. Lihe Wuhan New Chemical Materials Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 166. Lihe Wuhan New Chemical Materials Main Business
Table 167. Lihe Wuhan New Chemical Materials Latest Developments
Table 168. Shanghai Huachu Chemical Basic Information, Montelukast Manufacturing Base, Sales Area and Its Competitors
Table 169. Shanghai Huachu Chemical Montelukast Product Portfolios and Specifications
Table 170. Shanghai Huachu Chemical Montelukast Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 171. Shanghai Huachu Chemical Main Business
Table 172. Shanghai Huachu Chemical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Montelukast
Figure 2. Montelukast Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Montelukast Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Montelukast Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Montelukast Amorphous
Figure 10. Product Picture of Montelukast Crystalline
Figure 11. Global Montelukast Sales Market Share by Type in 2022
Figure 12. Global Montelukast Revenue Market Share by Type (2018-2023)
Figure 13. Montelukast Consumed in Tablets
Figure 14. Global Montelukast Market: Tablets (2018-2023) & (Kiloton)
Figure 15. Montelukast Consumed in Chewable Tablet
Figure 16. Global Montelukast Market: Chewable Tablet (2018-2023) & (Kiloton)
Figure 17. Montelukast Consumed in Oral Solution
Figure 18. Global Montelukast Market: Oral Solution (2018-2023) & (Kiloton)
Figure 19. Global Montelukast Sales Market Share by Application (2022)
Figure 20. Global Montelukast Revenue Market Share by Application in 2022
Figure 21. Montelukast Sales Market by Company in 2022 (Kiloton)
Figure 22. Global Montelukast Sales Market Share by Company in 2022
Figure 23. Montelukast Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Montelukast Revenue Market Share by Company in 2022
Figure 25. Global Montelukast Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Montelukast Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Montelukast Sales 2018-2023 (Kiloton)
Figure 28. Americas Montelukast Revenue 2018-2023 ($ Millions)
Figure 29. APAC Montelukast Sales 2018-2023 (Kiloton)
Figure 30. APAC Montelukast Revenue 2018-2023 ($ Millions)
Figure 31. Europe Montelukast Sales 2018-2023 (Kiloton)
Figure 32. Europe Montelukast Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Montelukast Sales 2018-2023 (Kiloton)
Figure 34. Middle East & Africa Montelukast Revenue 2018-2023 ($ Millions)
Figure 35. Americas Montelukast Sales Market Share by Country in 2022
Figure 36. Americas Montelukast Revenue Market Share by Country in 2022
Figure 37. Americas Montelukast Sales Market Share by Type (2018-2023)
Figure 38. Americas Montelukast Sales Market Share by Application (2018-2023)
Figure 39. United States Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Montelukast Sales Market Share by Region in 2022
Figure 44. APAC Montelukast Revenue Market Share by Regions in 2022
Figure 45. APAC Montelukast Sales Market Share by Type (2018-2023)
Figure 46. APAC Montelukast Sales Market Share by Application (2018-2023)
Figure 47. China Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Montelukast Sales Market Share by Country in 2022
Figure 55. Europe Montelukast Revenue Market Share by Country in 2022
Figure 56. Europe Montelukast Sales Market Share by Type (2018-2023)
Figure 57. Europe Montelukast Sales Market Share by Application (2018-2023)
Figure 58. Germany Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Montelukast Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Montelukast Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Montelukast Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Montelukast Sales Market Share by Application (2018-2023)
Figure 67. Egypt Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Montelukast in 2022
Figure 73. Manufacturing Process Analysis of Montelukast
Figure 74. Industry Chain Structure of Montelukast
Figure 75. Channels of Distribution
Figure 76. Global Montelukast Sales Market Forecast by Region (2024-2029)
Figure 77. Global Montelukast Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Montelukast Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Montelukast Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Montelukast Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Montelukast Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Montelukast
Figure 2. Montelukast Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Montelukast Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Montelukast Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Montelukast Amorphous
Figure 10. Product Picture of Montelukast Crystalline
Figure 11. Global Montelukast Sales Market Share by Type in 2022
Figure 12. Global Montelukast Revenue Market Share by Type (2018-2023)
Figure 13. Montelukast Consumed in Tablets
Figure 14. Global Montelukast Market: Tablets (2018-2023) & (Kiloton)
Figure 15. Montelukast Consumed in Chewable Tablet
Figure 16. Global Montelukast Market: Chewable Tablet (2018-2023) & (Kiloton)
Figure 17. Montelukast Consumed in Oral Solution
Figure 18. Global Montelukast Market: Oral Solution (2018-2023) & (Kiloton)
Figure 19. Global Montelukast Sales Market Share by Application (2022)
Figure 20. Global Montelukast Revenue Market Share by Application in 2022
Figure 21. Montelukast Sales Market by Company in 2022 (Kiloton)
Figure 22. Global Montelukast Sales Market Share by Company in 2022
Figure 23. Montelukast Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Montelukast Revenue Market Share by Company in 2022
Figure 25. Global Montelukast Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Montelukast Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Montelukast Sales 2018-2023 (Kiloton)
Figure 28. Americas Montelukast Revenue 2018-2023 ($ Millions)
Figure 29. APAC Montelukast Sales 2018-2023 (Kiloton)
Figure 30. APAC Montelukast Revenue 2018-2023 ($ Millions)
Figure 31. Europe Montelukast Sales 2018-2023 (Kiloton)
Figure 32. Europe Montelukast Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Montelukast Sales 2018-2023 (Kiloton)
Figure 34. Middle East & Africa Montelukast Revenue 2018-2023 ($ Millions)
Figure 35. Americas Montelukast Sales Market Share by Country in 2022
Figure 36. Americas Montelukast Revenue Market Share by Country in 2022
Figure 37. Americas Montelukast Sales Market Share by Type (2018-2023)
Figure 38. Americas Montelukast Sales Market Share by Application (2018-2023)
Figure 39. United States Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Montelukast Sales Market Share by Region in 2022
Figure 44. APAC Montelukast Revenue Market Share by Regions in 2022
Figure 45. APAC Montelukast Sales Market Share by Type (2018-2023)
Figure 46. APAC Montelukast Sales Market Share by Application (2018-2023)
Figure 47. China Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Montelukast Sales Market Share by Country in 2022
Figure 55. Europe Montelukast Revenue Market Share by Country in 2022
Figure 56. Europe Montelukast Sales Market Share by Type (2018-2023)
Figure 57. Europe Montelukast Sales Market Share by Application (2018-2023)
Figure 58. Germany Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Montelukast Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Montelukast Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Montelukast Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Montelukast Sales Market Share by Application (2018-2023)
Figure 67. Egypt Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Montelukast Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Montelukast in 2022
Figure 73. Manufacturing Process Analysis of Montelukast
Figure 74. Industry Chain Structure of Montelukast
Figure 75. Channels of Distribution
Figure 76. Global Montelukast Sales Market Forecast by Region (2024-2029)
Figure 77. Global Montelukast Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Montelukast Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Montelukast Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Montelukast Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Montelukast Revenue Market Share Forecast by Application (2024-2029)
